CLINICAL EVIDENCE
Access clinical and scientific evidence validating the performance of miLab™.
Evaluating the diagnostic performance of miLab™ for detection of malaria parasites using nPCR as reference standard
Malaria Journal | Ebenezer Kojo Addae, et al. | 2026.02
malaria · nPCR · Ghana · AI diagnostics
Diagnostic performance of the miLab MAL AI-driven automated digital microscopy system versus standard microscopy for Plasmodium spp. detection
Journal of Clinical Microbiology (JCM) | Lorra Monpierre, et al. | 2026.10
malaria · Plasmodium · France · AI diagnostics
[IPVS 2026] Improving Diagnostic Sensitivity in Cervical Cytology: A Comparative Study of an Automated AI-Integrated Workflow versus Manual Microscopy
IPVS 2026 | Mijin Kim, et al. | 2026.10
cervical cancer · digital cytology · AI diagnostics · inter-observer agreement
[LMCE 2026] Comparative Analytical Evaluation of Automated Pre-classification by Two Digital Morphology Analyzers against Manual Microscopy for Leukocyte Differential and Abnormal Cell Detection
LMCE 2026 (Laboratory Medicine Congress & Exhibition, Seoul) | C.Y. Bae, et al. | 2026.10
miLab BCM · digital morphology · AI WBC differential · immature granulocytes
[EAPS 2026] Analytical Reliability of an AI-Powered Micro-Volume Digital Haematology Analyser across Infant, Paediatric, and Adult Specimens
EAPS 2026 (12th Congress of the European Academy of Paediatric Societies, Athens) | C.Y. Bae, et al. | 2026.09
miLab BCM · paediatric haematology · neonatal CBC · micro-volume blood test
[ECP 2026] Diagnostic Performance of the miLab™ BCM for Morphological Detection of Blasts and Immature Granulocytes in Peripheral Blood
ECP 2026 (European Congress of Pathology) | C.Y. Bae, et al. | 2026.09
miLab BCM · blast detection · immature granulocytes · digital morphology
Disclaimer
- 1. Intended audience: This website is intended solely for healthcare professionals. It is not intended for patients or the general public. By selecting “Yes” on the access confirmation, you confirm that you are a healthcare professional.
- 2. Country-specific regulatory status: miLab™ products and their intended uses are approved, cleared, or registered on a country-by-country basis. Products, indications, test items, or features referenced on this website may not be available or authorized in your country. Nothing on this website should be interpreted as promotion of, or a recommendation for, any use not authorized in your country.
- 3. Scientific content: Publications, posters, abstracts, and webinars are presented as they were published or presented by their authors. They may include investigational or Research Use Only (RUO) data. Their content reflects the views of the authors, does not necessarily reflect the views of Noul Co., Ltd. (“Noul”), and does not constitute product claims by Noul.
- 4. No medical advice: Content on this website is provided for scientific and educational purposes only and is not a substitute for professional medical judgment, diagnosis, or treatment decisions.
- 5. Third-party links: Links to journals, congresses, and other external websites are provided for convenience only. Noul is not responsible for the content or availability of external websites, and all intellectual property rights in such content remain with the respective rights holders.
- 6. Updates and limitation of liability: Information on this website is current as of the time of publication and may be subject to change without notice. To the extent permitted by applicable law, Noul shall not be liable for any damages arising from the use of this website or its content.